Relay Therapeutics (RLAY) Current Leases (2019 - 2026)
Relay Therapeutics (RLAY) posted quarterly Current Leases of $3.9 million for Q1 2026, down 34.44% year-over-year from $5.9 million in Q1 2025, and up 3.27% quarter-over-quarter from $3.8 million in Q4 2025.
Relay Therapeutics (RLAY) Current Leases (2019 - 2026) Analysis & Trends
Relay Therapeutics (RLAY) has reported Current Leases for 8 consecutive years, with $3.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases fell 34.44% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $3.9 million (down 34.44% YoY), while the FY2025 annual figure was $3.8 million, down 34.26% from the prior year.
- Current Leases climbed to $3.9 million in Q1 2026 per RLAY's latest filing, from $3.8 million in the prior quarter.
- Across five years, Current Leases topped out at $5.9 million in Q1 2025 and bottomed at $1.9 million in Q1 2022.
- Historically, Current Leases has averaged $4.4 million across 5 years, with a median of $4.6 million in 2023.
- Annual changes were most pronounced in 2022 — Current Leases surged 221.32% — and 2026, when it tumbled 34.44%.
- Relay Therapeutics' Current Leases stood at $4.3 million in 2022, then gained by 16.09% to $5.0 million in 2023, then gained by 15.37% to $5.7 million in 2024, then tumbled by 34.26% to $3.8 million in 2025, then advanced by 3.27% to $3.9 million in 2026.
- Business Quant data shows RLAY's Current Leases at $3.9 million in Q1 2026, $3.8 million in Q4 2025, and $3.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Relay Therapeutics | 4.34 Bn | 4.34 Bn | - | 4.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.01 Mn |
| Mar 31, 2026 | 3.89 Mn |
| Dec 31, 2025 | 3.77 Mn |
| Sep 30, 2025 | 3.64 Mn |
| Jun 30, 2025 | 3.53 Mn |
| Mar 31, 2025 | 5.93 Mn |
| Dec 31, 2024 | 5.73 Mn |
| Sep 30, 2024 | 5.53 Mn |
| Jun 30, 2024 | 5.34 Mn |
| Mar 31, 2024 | 5.15 Mn |
| Dec 31, 2023 | 4.96 Mn |
| Sep 30, 2023 | 4.79 Mn |
| Jun 30, 2023 | 4.61 Mn |
| Mar 31, 2023 | 4.44 Mn |
| Dec 31, 2022 | 4.28 Mn |
| Sep 30, 2022 | 5.68 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Mar 31, 2022 | 1.92 Mn |
| Dec 31, 2021 | 1.84 Mn |
| Sep 30, 2021 | 1.77 Mn |